Table 2.

Biochemical parameters in the NAFLD and control groups.

Parameter	Group	Baseline	Three months post-treatment	Six months post-treatment
FBS	Weight loss	106.2 ± 14.9	101.5 ± 10.8	94.1 ± 11.7
	Non-weight loss	108.4 ± 11.9	104.7 ± 10.5	101.8 ± 8.7
	p-value	0.299	0.117	0.024
Triglyceride	Weight loss	164.3 ± 92.9	141.5 ± 66.1	126.8 ± 60.9
	Non-weight loss	168.6 ± 74.3	159.6 ± 52.9	151.7 ± 48.7
	p-value	0.492	0.041	0.037
Total cholesterol	Weight loss	182.3 ± 35.9	172.6 ± 29.1	161.8 ± 28.5
	Non-weight loss	179.3 ± 28.7	174.3 ± 23.3	170.2 ± 22.8
	p-value	0.529	0.493	0.031
LDL cholesterol	Weight loss	105.7 ± 31.8	99.9 ± 26.5	93.4 ± 26.4
	Non-weight loss	108.8 ± 25.4	105.1 ± 21.2	103.3 ± 21.1
	p-value	0.198	0.074	0.011
HDL cholesterol	Weight loss	37.1 ± 8.3	39.4 ± 5.2	42.8 ± 5.1
	Non-weight loss	36.2 ± 5.9	37.3 ± 4.7	38.9 ± 5.3
	p-value	0.271	0.119	0.064
AST	Weight loss	41.2 ± 7.3	39.3 ± 6.4	32.1 ± 8.2
	Non-weight loss	44.3 ± 10.1	43.1 ± 7.9	41.9 ± 9.4
	p-value	0.573	0.821	0.027
ALT	Weight loss	52.7 ± 51.7	46.8 ± 36.9	39.8 ± 32.8
	Non-weight loss	57.3 ± 8.4	51.9 ± 8.5	49.7 ± 8.3
	p-value	0.481	0.311	0.035
ALKP	Weight loss	281.7 ± 170.6	249.4 ± 126.9	221.5 ± 127.1
	Non-weight loss	293.1 ± 96.9	284.3 ± 74.2	266.4 ± 54.8
	p-value	0.077	0.048	0.006